Avellino Labs

Avellino’s mission is to ethically and securely collect, organize and share genetic data to maximize its predictive diagnostic and therapeutic benefits to accelerate positive outcomes for individuals worldwide. As a global leader in leveraging artificial intelligence-powered algorithms, Avellino’s diagnostics provide eye care professionals with personalized genetic data to predict eye disease, prevent disease progression and preserve vision. Its R&D team has made groundbreaking discoveries in early detection of oncology, a polygenic risk score for glaucoma, and a siRNA gene-silencing therapeutic for the treatment of granular corneal dystrophy type II. Avellino is headquartered in California, with operations in Korea, Japan and the United Kingdom.